12 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $3.3B | -$78M | 0.0% | 11.8% | $196M | $3.7B | $240M |
| 2024 | $3.1B | -$168M | 0.0% | 11.2% | $210M | $3.4B | $270M |
| 2023 | $2.7B | -$12M | 0.0% | 12.0% | $205M | $2.8B | $196M |
| 2022 | $2.5B | -$55M | 0.0% | 13.6% | $78M | $2.6B | $283M |
| 2021 | $2.2B | -$71M | 0.0% | 13.6% | $30M | $3.0B | $390M |
| 2020 | $1.9B | -$116M | 0.0% | 9.8% | $204M | $2.9B | $318M |
| 2019 | $1.8B | -$75M | 23.1% | 12.9% | $56M | $2.6B | $93M |
| 2018 | $1.8B | -$206M | 23.1% | 4.4% | $105M | $2.3B | $184M |
| 2016 | $1.1B | $9M | 28.3% | 17.2% | $86M | $1.5B | $70M |
| 2015 | — | $1M | — | — | $51M | $1.3B | $58M |
| 2014 | — | -$66M | — | — | $14M | — | $75M |
| 2013 | — | -$9M | — | — | $45M | — | $13M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $811M | -$36M | 0.0% | 8.1% | -$4M | — | $182M |
| Dec '25 | $885M | -$15M | 0.0% | 12.5% | $91M | $3.7B | $240M |
| Sep '25 | $822M | -$23M | 0.0% | 12.9% | $64M | — | $203M |
| Jun '25 | $826M | -$3M | 0.0% | 13.5% | $58M | — | $250M |
| Mar '25 | $776M | -$38M | 0.0% | 8.0% | -$17M | — | $229M |
| Dec '24 | $864M | -$109M | 0.0% | 14.7% | $89M | $3.4B | $270M |
| Sep '24 | $770M | -$32M | 0.0% | 7.9% | $45M | — | $222M |
| Jun '24 | $762M | -$16M | 0.0% | 11.1% | $56M | — | $214M |
| Mar '24 | $717M | -$12M | 0.0% | 10.6% | $20M | — | $185M |
| Dec '23 | $735M | -$1M | 0.0% | 13.8% | $43M | $2.8B | $196M |
| Sep '23 | $674M | -$5M | 0.0% | 12.3% | $86M | — | $236M |
| Jun '23 | $668M | $19M | 0.0% | 14.6% | $26M | — | $177M |
| Mar '23 | $666M | -$25M | 0.0% | 7.0% | $50M | — | $246M |
| Dec '22 | $707M | -$23M | 0.0% | 13.3% | -$16M | $2.6B | $283M |
| Sep '22 | $621M | -$25M | 0.0% | 11.9% | $12M | — | $155M |
| Jun '22 | $615M | -$18M | 0.0% | 12.4% | $20M | — | $227M |
| Mar '22 | $596M | $12M | 0.0% | 16.8% | $62M | — | $379M |
| Dec '21 | $610M | -$100000 | 0.0% | 18.8% | $6M | $3.0B | $390M |
| Sep '21 | $559M | -$23M | 0.0% | 11.4% | -$600000 | — | $330M |
| Jun '21 | $543M | -$27M | 0.0% | 11.0% | -$11M | — | $465M |
How the market has priced SGRY against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Surgery Partners, Inc.'s revenue has grown 12.2% per year. These are computed facts, not advice.
As of FY2025, Surgery Partners, Inc. reported $3.7B of total debt against $240M of cash.
In FY2025, gross margin was —, operating margin 11.8%, and net margin -2.4%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.